Diamines & Chemicals Limited (DIAMINESQ)

Loading page…

Diamines & Chemicals Limited (DIAMINESQ) · mywealthgrid

About

Diamines & Chemicals operates in specialty chemicals with market cap ₹238.21 Cr, positioned as a small-cap in the materials sector. Recent quarters show operational distress with deeply negative margins, though Jun 2026 marks the first quarter with positive operating margin.

Face value: ₹10

Market cap

₹239 Cr

P/E

—

P/B

1.5×

Dividend yield

0.4%

ROE

-8%

ROCE

-8.4%

Debt / equity

0.05

OPM

-35.9%

EPS (TTM)

₹-10.0

Book value

₹156.7

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

Operating margin of -35.89% with negative readings through Mar 2026; Jun 2026 shows 2.64–3.13% margin — verify if recovery is structural or cyclical

ROE at -8.02% signals capital destruction and limited capacity for organic growth investment

Revenue volatility from ₹7.64 Cr (Dec 2025) to ₹14.37 Cr (Jun 2026) — verify sustainability of recovery and underlying drivers

Negligible institutional holdings (FII 0%, DII 0.02%) may limit analyst coverage and valuation discipline — verify liquidity impact

Generated analysis · source review pending

Growth drivers

Revenue recovered 88% to ₹14.37 Cr (Jun 2026) from Dec 2025 trough of ₹7.64 Cr — verify if driven by demand recovery or cyclical upturn

Operating margin turned positive to 2.64–3.13% in Jun 2026, first time in recent quarters — verify if operational leverage is engaging or relief is temporary

Low debt burden (D/E 0.05) provides capacity for capex or working-capital investment if recovery sustains — verify management's investment thesis

Specialty chemicals sector typically commands higher margins than commodity chemicals — verify company's competitive positioning and pricing power

Generated analysis · source review pending

2,177 historical price candles were omitted because the exchange source has not been verified.

₹236.3-1.5%1Y

Quick read

rule-based

Pros

+Almost debt-free (debt/equity 0.1)

Cons

−Low return on equity of 1.6% (3-yr avg)
−Revenue shrank over the last 5 years (-9.3% a year)
−Weak interest coverage of -44×

Research score

Structured signal from quality, growth, valuation and momentum.

51/100

Business quality: 19
Growth: 37
Valuation: 98

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Gujarat Fluorochemicals LimitedFLUOROCHEMFLUOROCHEM	₹47,713 Cr	₹49,912 Cr	₹5,303 Cr	₹1,375 Cr	25.8%	₹615 Cr	11.5%	11.1%	7.6%	401
Navin Fluorine International LimitedNAVINFLUORNAVINFLUOR	₹41,740 Cr	₹42,967 Cr	₹3,634 Cr	₹1,232 Cr	32.6%	₹790 Cr	20%	21.6%	20.1%	61
Aether Industries LimitedAETHERAETHER	₹22,161 Cr	₹22,603 Cr	₹1,224 Cr	₹384 Cr	31.3%	₹235 Cr	19.8%	13.2%	9.4%	330
Atul LimitedATULATUL	₹17,231 Cr	₹17,411 Cr	₹6,643 Cr	₹1,189 Cr	16.4%	₹704 Cr	11%	14.1%	11.5%	70
Aarti Industries LimitedAARTIINDAARTIIND	₹16,869 Cr	₹21,790 Cr	₹9,012 Cr	₹1,337 Cr	14.1%	₹531 Cr	5.1%	8.8%	7.3%	54
Fine Organic Industries LimitedFINEORGFINEORG	₹15,752 Cr	₹15,797 Cr	₹2,472 Cr	₹535 Cr	20.4%	₹438 Cr	17.6%	21.6%	16.8%	113
Basf India LimitedBASFBASF	₹14,796 Cr	₹14,796 Cr	₹16,177 Cr	₹952 Cr	4.4%	₹643 Cr	2.8%	14%	11.1%	40
Privi Speciality Chemicals LimitedPRIVISCLPRIVISCL	₹13,970 Cr	₹14,980 Cr	₹2,671 Cr	₹666 Cr	25.2%	₹342 Cr	12.4%	27.7%	25.2%	158
Sudeep Pharma LimitedSUDEEPPHRMSUDEEPPHRM	₹13,546 Cr	₹13,694 Cr	₹676 Cr	₹233 Cr	34.6%	₹133 Cr	27.1%	31.1%	25.2%	366
Anupam Rasayan India LimitedANURASANURAS	₹13,243 Cr	₹15,058 Cr	₹2,535 Cr	₹563 Cr	22.2%	₹175 Cr	9.4%	9.1%	5.5%	377
Vinati Organics LimitedVINATIORGAVINATIORGA	₹12,528 Cr	₹12,528 Cr	₹2,381 Cr	₹665 Cr	29.4%	₹448 Cr	19.9%	18.8%	14.9%	152
Elantas Beck India LimitedELANTASELANTAS	₹10,644 Cr	₹10,644 Cr	₹778 Cr	₹147 Cr	20.3%	₹136 Cr	17.4%	20.6%	15.8%	70

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	63	66	111	104	71	38
COGS	18	21	28	48	36	22
Gross profit	45	45	83	56	35	17
	20	23	27	33	30	31
	25	22	55	22	5	-14
OPM %	39.9%	33.3%	50.1%	21.4%	7.3%	-36.5%
Depreciation	2	2	2	3	3	4
Interest	0	0	0	0	0	0
	3	2	3	3	3	4
Profit before tax	26	22	56	22	5	-14
Tax	5	5	14	6	2	-1
Tax %	18.6%	24.3%	25.6%	28.9%	40.1%	-9.9%
	21	17	42	15	3	-13
PAT margin %	33.4%	25.3%	37.9%	14.9%	3.8%	-33.2%
EPS (₹)	21.5	17.1	42.8	16.2	2.8	-13.1
EPS adjusted (₹)	21.5	17.1	42.8	15.8	2.8	-12.7
	23.3%	17.6%	14%	15.4%	35.8%	—
Annual report	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	10	10	10	10	10	10	10
Reserves	—	75	90	125	138	151	147
Minority interest	—	0	—	0	—	—	—
	—	0	0	0	0	0	8
	—	9	10	17	15	17	9
Total equity & liabilities	—	95	111	151	163	178	174
	20	22	38	40	65	64	65
CWIP	—	0	2	21	1	2	19
Investments	—	6	13	13	16	16	10
	—	66	58	76	81	96	80
Total assets	—	95	111	151	163	178	174

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	15	27	16	22	-5	-11
	-15	-21	-9	-19	15	-29
	-4	-5	-6	-3	10	18
Net cash flow	-3	1	2	-0	19	-22
Free cash flow	—	—	—	13	-9	-32
CFO / Operating profit %	61.4%	124.1%	29.4%	96.6%	-92.5%	—

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities	Capital employed	ROCE %
Speciality Chemicals	38.48	-10.07	174.44	16.94	157.5	-6.39
Trading in Fruits and Vegetables	0	-3.58

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	72.1%	68.5%	74.9%	53.5%	49.5%	43.2%
EBITDA margin %	39.9%	33.3%	50.1%	21.8%	7.6%	-35.9%
EBIT margin %	37%	30.7%	48.5%	19.1%	2.7%	-45.7%
PAT margin %	33.4%	25.3%	37.9%	14.9%	3.8%	-33.2%
Working capital
Receivable days	55	55	76	59	71	52
Inventory days	261	40	221	131	320	473
Payable days	60	42	99	39	89	45
NWC days	256	54	197	150	302	481
Leverage
Current ratio	9.61	8.43	5.44	7.3	7.36	5.12
Debt to EBITDA	0.01	0	0	0	0.01	—
Debt to equity	0	0	0	0	0	0.05
Interest coverage	—	737.7	2,819	111.9	15.1	-44
Asset turnover	0.66	0.6	0.73	0.64	0.4	0.22
Return ratios
Return on assets %	22.1%	15.1%	27.7%	9.5%	1.5%	-7.3%
Return on capital employed %	29%	22.9%	46.5%	15.4%	3.2%	-8.4%
Return on equity %	24.7%	16.7%	31.1%	10.4%	1.7%	-8.1%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	54.63%	54.63%	54.87%	54.87%	54.87%	54.87%	55.18%	55.2%	55.2%	55.34%	57.4%	57.5%
	0%	0%	0.04%	0%	0%	0%	0.02%	0%	0%	0%	0.08%	0%
	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.04%	0.02%	0.02%	0.02%	0.02%
	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	45.33%	45.33%	45.05%	45.09%	45.09%	45.09%	44.76%	44.76%	44.78%	44.64%	42.5%	42.48%
No. of shareholders	—	—	—	—	—	—	—	—	13,363	13,154	12,731	12,633

Promoter holding up 2.87 percentage points since Sep 2023.

Mr. Amit MehtaExecutive Director-Chairperson related to Promoter-CEO
Mr. Tanmay GodiawalaExecutive Director
Dipen RupareliaChief Financial Officer
Mr. Rajendra ChhabraNon-Executive - Non Independent Director
Mr. Priyam JhaveriNon-Executive - Independent Director
Mr. Dhruv MehtaNon-Executive - Independent Director
Mrs. Kejal PandyaNon-Executive - Independent Director
Ms. Hemaxi PawarCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Diamines & Chemicals Limited. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Annual reports

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

20

Final dividend28 Aug 2025 · ex-date₹1
Final dividend25 Jul 2024 · ex-date₹2.5
Final dividend13 Jun 2023 · ex-date₹3
Interim dividend24 Nov 2022 · ex-date₹3
Final dividend17 Jun 2022 · ex-date₹3
Final dividend12 Jul 2021 · ex-date₹5
Final dividend27 Aug 2020 · ex-date₹4
Interim dividend13 Feb 2020 · ex-date₹4
Final dividend31 Jul 2019 · ex-date₹2
Interim dividend6 Nov 2018 · ex-date₹3
Dividend dividend27 Jul 2018 · ex-date₹2.5
Dividend dividend10 Jul 2017 · ex-date₹1.5
Dividend dividend10 Jul 2013 · ex-date₹0.5
Dividend dividend26 Jul 2012 · ex-date₹1
Final dividend19 Jul 2011 · ex-date₹4.5
Interim dividend2 Nov 2010 · ex-date₹1.5
Dividend dividend7 Jul 2010 · ex-date₹2
Dividend dividend8 Jul 2009 · ex-date₹1
Dividend dividend23 Jul 2008 · ex-date₹1
Dividend dividend11 Jul 2007 · ex-date₹2.5

1

Board meeting to consider results5 Aug 2026

1

Bonus 1:219 Jul 2011 · ex-date

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

10 announcementsExport CSV

28 Sept 2026, 4:58 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

28 Sept 2026, 4:47 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Management

Change in Management PDF

16 Sept 2026, 5:14 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

AGM PDF

16 Sept 2026, 5:10 pmAGM/EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

AGM PDF

8 Sept 2026, 3:35 pmCompany Update

Announcement Under Regulation 30 - Update

General PDF

26 Aug 2026, 11:21 amCompany Update

Update On Submission Dated August 05, 2026 - Disclosure For Allotment Of Shares Under DACL- ESOP 2021

General PDF

14 Aug 2026, 1:50 pmCompany Update

Diamines & Chemicals Ltd-$ - 500120 - A Letter Containing The Exact Web-Link And Path For Accessing The Annual Report For FY 2025-26

General PDF

14 Aug 2026, 1:44 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

Date	Category	Subject	Filing
28 Sept 2026, 4:58 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
28 Sept 2026, 4:47 pm	Company Update Change in Management	Announcement under Regulation 30 (LODR)-Change in Management

Loading announcements…

Diamines & Chemicals Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Segment results

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

20

1

1

Announcements

20

1

1

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Segment results

Compounded sales growth

Return on equity

Speciality Chemicals · revenue

Diamines & Chemicals Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Segment results

Ratios

Ratio timeline

Shareholding

Quarterly record

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

Dividends20

Board meetings1

Bonus issues1

Announcements

Dividends20

Board meetings1

Bonus issues1

Ratio timeline

Quarterly record

Board and management

Not in the F&O segment

No fund holdings on record

Announcements

Annual reports

Profit & loss

Balance sheet

Cash flow

Segment results

Compounded returns

Compounded sales growth

Return on equity

Speciality Chemicals · revenue

20

1

1

20

1

1